m6A modification of non‑coding RNA: Mechanisms, functions and potential values in human diseases (Review)

Liang W, Yi H, Mao C, Meng Q, Wu X, Li S and Xue J: Research progress of RNA methylation modification in colorectal cancer. Front Pharmacol. 13:9036992022. View Article : Google Scholar : PubMed/NCBI

Li Y, Jin H, Li Q, Shi L, Mao Y and Zhao L: The role of RNA methylation in tumor immunity and its potential in immunotherapy. Mol Cancer. 23:1302024. View Article : Google Scholar : PubMed/NCBI

Wen T, Li T, Xu Y, Zhang Y, Pan H and Wang Y: The role of m6A epigenetic modifications in tumor coding and non-coding RNA processing. Cell Commun Signal. 21:3552023. View Article : Google Scholar : PubMed/NCBI

An Y and Duan H: The role of m6A RNA methylation in cancer metabolism. Mol Cancer. 21:142022. View Article : Google Scholar : PubMed/NCBI

Zhang Q and Xu K: The role of regulators of RNA m⁶A methylation in lung cancer. Genes Dis. 10:495–504. 2023. View Article : Google Scholar

Mendel M, Chen KM, Homolka D, Gos P, Pandey RR, McCarthy AA and Pillai RS: Methylation of structured RNA by the m⁶A writer METTL16 is essential for mouse embryonic development. Mol Cell. 71:986–1000.e1011. 2018. View Article : Google Scholar

Ma H, Hong Y, Xu Z, Weng Z, Yang Y, Jin D, Chen Z, Yue J, Zhou X, Xu Z, et al: N⁶-methyladenosine (m⁶A) modification in hepatocellular carcinoma. Biomed Pharmacother. 173:1163652024. View Article : Google Scholar

Qu Y, Gao N, Zhang S, Gao L, He B, Wang C, Gong C, Shi Q, Li Z, Yang S and Xiao Y: Role of N6-methyladenosine RNA modification in cancer. MedComm (2020). 5:e7152024. View Article : Google Scholar : PubMed/NCBI

Guttman M and Rinn JL: Modular regulatory principles of large non-coding RNAs. Nature. 482:339–346. 2012. View Article : Google Scholar : PubMed/NCBI

Nemeth K, Bayraktar R, Ferracin M and Calin GA: Non-coding RNAs in disease: From mechanisms to therapeutics. Nat Rev Genet. 25:211–232. 2024. View Article : Google Scholar

Gao K, Li X, Ni J, Wu B, Guo J, Zhang R and Wu G: Non-coding RNAs in enzalutamide resistance of castration-resistant prostate cancer. Cancer Lett. 566:2162472023. View Article : Google Scholar : PubMed/NCBI

Kopp F and Mendell JT: Functional classification and experimental dissection of long noncoding RNAs. Cell. 172:393–407. 2018. View Article : Google Scholar : PubMed/NCBI

Fabian MR, Sonenberg N and Filipowicz W: Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem. 79:351–379. 2010. View Article : Google Scholar : PubMed/NCBI

Zhou WY, Cai ZR, Liu J, Wang DS, Ju HQ and Xu RH: Circular RNA: Metabolism, functions and interactions with proteins. Mol Cancer. 19:1722020. View Article : Google Scholar : PubMed/NCBI

Ning K, Zhao J, Feng Z, Park SY, McFarlin S, Cheng F, Yan Z, Wang J and Qiu J: N6-methyladenosine modification of a parvovirus-encoded small noncoding RNA facilitates viral DNA replication through recruiting Y-family DNA polymerases. Proc Natl Acad Sci USA. 121:e23207821212024. View Article : Google Scholar : PubMed/NCBI

Garbo S, D'Andrea D, Colantoni A, Fiorentino F, Mai A, Ramos A, Tartaglia GG, Tancredi A, Tripodi M and Battistelli C: m6A modification inhibits miRNAs' intracellular function, favoring their extracellular export for intercellular communication. Cell Rep. 43:1143692024. View Article : Google Scholar : PubMed/NCBI

Duan JL, Chen W, Xie JJ, Zhang ML, Nie RC, Liang H, Mei J, Han K, Xiang ZC, Wang FW, et al: A novel peptide encoded by N6-methyladenosine modified circMAP3K4 prevents apoptosis in hepatocellular carcinoma. Mol Cancer. 21:932022. View Article : Google Scholar : PubMed/NCBI

Zhou J, Yao L, Su Y and Tian L: IGF2BP3 loss inhibits cell progression by upregulating has_circRNA_103820, and hsa_ circRNA_103820-encoded peptide inhibits cell progression by inactivating the AKT pathway in lung cancer. Chem Biol Drug Des. 103:e144732024. View Article : Google Scholar

Desrosiers R, Friderici K and Rottman F: Identification of methylated nucleosides in messenger RNA from Novikoff hepatoma cells. Proc Natl Acad Sci USA. 71:3971–3975. 1974. View Article : Google Scholar : PubMed/NCBI

Huang H, Weng H and Chen J: m⁶A modification in coding and non-coding RNAs: Roles and therapeutic implications in cancer. Cancer Cell. 37:270–288. 2020. View Article : Google Scholar : PubMed/NCBI

Liang J, Yi Q, Liu Y, Li J, Yang Z and Sun W and Sun W: Recent advances of m6A methylation in skeletal system disease. J Transl Med. 22:1532024. View Article : Google Scholar : PubMed/NCBI

Qiao Y, Mei Y, Xia M, Luo D and Gao L: The role of m6A modification in the risk prediction and Notch1 pathway of Alzheimer's disease. iScience. 27:1102352024. View Article : Google Scholar : PubMed/NCBI

Zhu L, Zhang H, Zhang X and Xia L: RNA m6A methylation regulators in sepsis. Mol Cell Biochem. 479:2165–2180. 2024. View Article : Google Scholar

Lu W, Yang X, Zhong W, Chen G, Guo X, Ye Q, Xu Y, Qi Z, Ye Y, Zhang J, et al: METTL14-mediated m6A epitranscriptomic modification contributes to chemotherapy-induced neuropathic pain by stabilizing GluN2A expression via IGF2BP2. J Clin Invest. 134:e1748472024. View Article : Google Scholar : PubMed/NCBI

Wu S, Wang H, Yang Q, Liu Z, Du J, Wang L, Chen S, Lu Q and Yang D: METTL3 regulates M6A methylation-modified EBV-pri-miR-BART3-3p to promote NK/T cell lymphoma growth. Cancer Lett. 597:2170582024. View Article : Google Scholar : PubMed/NCBI

Liu X, Feng M, Hao X, Gao Z, Wu Z, Wang Y, Du L and Wang C: m6A methylation regulates hypoxia-induced pancreatic cancer glycolytic metabolism through ALKBH5-HDAC4-HIF1α positive feedback loop. Oncogene. 42:2047–2060. 2023. View Article : Google Scholar : PubMed/NCBI

Ning J, Yan J, Wang S, Cui Z, Xue Y, Juan J and Yang H: Demethylase FTO-mediated m6A modification of SIK1 modulates placental cytotrophoblast syncytialization in type 2 diabetes mellitus. iScience. 27:1099002024. View Article : Google Scholar : PubMed/NCBI

Shu F, Liu H, Chen X, Liu Y, Zhou J, Tang L, Cao W, Yang S, Long Y, Li R, et al: m6A modification promotes EMT and metastasis of castration-resistant prostate cancer by upregulating NFIB. Cancer Res. 84:1947–1962. 2024. View Article : Google Scholar : PubMed/NCBI

Zhang X, Su T, Wu Y, Cai Y, Wang L, Liang C, Zhou L, Wang S, Li XX, Peng S, et al: N6-Methyladenosine reader YTHDF1 promotes stemness and therapeutic resistance in hepatocellular carcinoma by enhancing NOTCH1 expression. Cancer Res. 84:827–840. 2024. View Article : Google Scholar : PubMed/NCBI

Li F, Wang F, Wang L, Wang J, Wei S, Meng J, Li Y, Feng L and Jiang P: m6A reader YTHDC2 mediates NCOA4 mRNA stability affecting ferritinophagy to alleviate secondary injury after intracerebral haemorrhage. Epigenetics. 19:23268682024. View Article : Google Scholar : PubMed/NCBI

Klein P, Howe MP, Harley J, Crook H, Serna SE, Roumeliotis TI, Choudhary JS, Chakrabarti AM, Luisier R, Patani R and Ramos A: m6a methylation orchestrates IMP1 regulation of microtubules during human neuronal differentiation. Nat Commun. 15:48192024. View Article : Google Scholar : PubMed/NCBI

Xia T, Dai XY, Sang MY, Zhang X, Xu F, Wu J, Shi L, Wei JF and Ding Q: IGF2BP2 drives cell cycle progression in triple-negative breast cancer by recruiting EIF4A1 to promote the m6A-modified CDK6 translation initiation process. Adv Sci (Weinh). 11:e23051422024. View Article : Google Scholar

Lv L, Wei Q, Zhang J, Dong Y, Shan Z, Chang N, Zhao Y, Bian P and Yi Q: IGF2BP3 prevent HMGB1 mRNA decay in bladder cancer and development. Cell Mol Biol Lett. 29:392024. View Article : Google Scholar : PubMed/NCBI

Wang X, Lu X, Wang P, Chen Q, Xiong L, Tang M, Hong C, Lin X, Shi K, Liang L and Lin J: SRSF9 promotes colorectal cancer progression via stabilizing DSN1 mRNA in an m6A-related manner. J Transl Med. 20:1982022. View Article : Google Scholar : PubMed/NCBI

Shi S, Chen Q, Yang Y, Li Z, Zheng R, Zhang R, Liu Z and Cheng Y: HnRNPA2B1 promotes cardiac ferroptosis via m6A-dependent stabilization of PFN2 mRNA in myocardial ischemia-reperfusion injury. Free Radic Biol Med. 232:231–243. 2025. View Article : Google Scholar : PubMed/NCBI

Baek A, Lee GE, Golconda S, Rayhan A, Manganaris AA, Chen S, Tirumuru N, Yu H, Kim S, Kimmel C, et al: Single-molecule epitranscriptomic analysis of full-length HIV-1 RNAs reveals functional roles of site-specific m⁶As. Nat Microbiol. 9:1340–1355. 2024. View Article : Google Scholar : PubMed/NCBI

McIntyre ABR, Alexander N, Grigorev K, Bezdan D, Sichtig H, Chiu CY and Mason C: Single-molecule sequencing detection of N6-methyladenine in microbial reference materials. Nat Commun. 10:5792019. View Article : Google Scholar : PubMed/NCBI

Song M, Wang J, Hou J, Fu T, Feng Y, Lv W, Ge F, Peng R, Han D and Tan W: Multiplexed in situ imaging of site-specific m6A methylation with proximity hybridization followed by primer exchange amplification (m6A-PHPEA). ACS Nano. 18:27537–27546. 2024. View Article : Google Scholar : PubMed/NCBI

Zhang Q, Dai Y, Teng X and Li J: Visualization and quantification of single-Base m⁶A methylation. Angew Chem Int Ed Engl. 64:e2024209772025. View Article : Google Scholar

Yi Q, Xie W, Sun W, Sun W and Liao Y: A concise review of MicroRNA-383: Exploring the insights of its function in tumorigenesis. J Cancer. 13:313–324. 2022. View Article : Google Scholar : PubMed/NCBI

Bartel DP: MicroRNAs: Target recognition and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI

Yi Q, Cui H, Liao Y, Xiong J, Ye X and Sun W: A minor review of microRNA-338 exploring the insights of its function in tumorigenesis. Biomed Pharmacother. 139:1117202021. View Article : Google Scholar : PubMed/NCBI

Valadkhan S: snRNAs as the catalysts of pre-mRNA splicing. Curr Opin Chem Biol. 9:603–608. 2005. View Article : Google Scholar : PubMed/NCBI

Liu Y, Liu X, Lin C, Jia X, Zhu H, Song J and Zhang Y: Noncoding RNAs regulate alternative splicing in cancer. J Exp Clin Cancer Res. 40:112021. View Article : Google Scholar : PubMed/NCBI

Zhang X, Hong R, Chen W, Xu M and Wang L: The role of long noncoding RNA in major human disease. Bioorg Chem. 92:1032142019. View Article : Google Scholar : PubMed/NCBI

Statello L, Guo CJ, Chen LL and Huarte M: Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol. 22:96–118. 2021. View Article : Google Scholar

Wu H, Yang L and Chen LL: The diversity of long noncoding RNAs and their generation. Trends Genet. 33:540–552. 2017. View Article : Google Scholar : PubMed/NCBI

Liu Y, Ding W, Yu W, Zhang Y, Ao X and Wang J: Long non-coding RNAs: Biogenesis, functions, and clinical significance in gastric cancer. Mol Ther Oncolytics. 23:458–476. 2021. View Article : Google Scholar : PubMed/NCBI

Sengupta P, Roy A, Roy L, Bose D, Halder S, Jana K, Mukherjee G and Chatterjee S: Long non-coding intergenic RNA, LINC00273 induces cancer metastasis and stemness via miRNA sponging in triple negative breast cancer. Int J Biol Macromol. 274:1327302024. View Article : Google Scholar : PubMed/NCBI

Yao ZT, Yang YM, Sun MM, He Y, Liao L, Chen KS and Li B: New insights into the interplay between long non-coding RNAs and RNA-binding proteins in cancer. Cancer Commun (Lond). 42:117–140. 2022. View Article : Google Scholar : PubMed/NCBI

Zhang Z, Zhou K, Han L, Small A, Xue J, Huang H, Weng H, Su R, Tan B, Shen C, et al: RNA m⁶A reader YTHDF2 facilitates precursor miR-126 maturation to promote acute myeloid leukemia progression. Genes Dis. 11:382–396. 2024. View Article : Google Scholar

Liu CX and Chen LL: Circular RNAs: Characterization, cellular roles, and applications. Cell. 185:2016–2034. 2022. View Article : Google Scholar : PubMed/NCBI

Chen LL: The biogenesis and emerging roles of circular RNAs. Nat Rev Mol Cell Biol. 17:205–211. 2016. View Article : Google Scholar : PubMed/NCBI

Yi Q, Feng J, Liao Y and Sun W: Circular RNAs in chemotherapy resistance of lung cancer and their potential therapeutic application. IUBMB Life. 75:225–237. 2023. View Article : Google Scholar

Conn VM, Chinnaiyan AM and Conn SJ: Circular RNA in cancer. Nat Rev Cancer. 24:597–613. 2024. View Article : Google Scholar : PubMed/NCBI

Kristensen LS, Andersen MS, Stagsted LVW, Ebbesen KK, Hansen TB and Kjems J: The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 20:675–691. 2019. View Article : Google Scholar : PubMed/NCBI

Dayal S, Chaubey D, Joshi DC, Ranmale S and Pillai B: Noncoding RNAs: Emerging regulators of behavioral complexity. Wiley Interdiscip Rev RNA. 15:e18472024. View Article : Google Scholar : PubMed/NCBI

Yi Q, Feng J, Lan W, Shi H and Sun W and Sun W: CircRNA and lncRNA-encoded peptide in diseases, an update review. Mol Cancer. 23:2142024. View Article : Google Scholar : PubMed/NCBI

Li Y, Wang Z, Yang J, Sun Y, He Y, Wang Y, Chen X, Liang Y, Zhang N, Wang X, et al: CircTRIM1 encodes TRIM1-269aa to promote chemoresistance and metastasis of TNBC via enhancing CaM-dependent MARCKS translocation and PI3K/AKT/mTOR activation. Mol Cancer. 23:1022024. View Article : Google Scholar : PubMed/NCBI

Alarcón CR, Lee H, Goodarzi H, Halberg N and Tavazoie SF: N6-methyladenosine marks primary microRNAs for processing. Nature. 519:482–485. 2015. View Article : Google Scholar : PubMed/NCBI

Chen L, Hu Y, Zhang M, Liu L, Ma J, Xu Z, Zhang J, Gu H and Chen K: METTL14 affects UVB-induced human dermal fibroblasts photoaging via miR-100-3p biogenesis in an m⁶A-dependent manner. Aging Cell. 23:e141232024. View Article : Google Scholar

Chen P, Li S, Zhang K, Zhao R, Cui J, Zhou W, Liu Y, Zhang L and Cheng Y: N⁶-methyladenosine demethylase ALKBH5 suppresses malignancy of esophageal cancer by regulating microRNA biogenesis and RAI1 expression. Oncogene. 40:5600–5612. 2021. View Article : Google Scholar : PubMed/NCBI

Ding D, Shang W, Shi K, Ying J, Wang L, Chen Z and Zhang C: FTO/m6A mediates miR-138-5p maturation and regulates gefitinib resistance of lung adenocarcinoma cells by miR-138-5p/LCN2 axis. BMC Cancer. 24:12702024. View Article : Google Scholar : PubMed/NCBI

Hou Y, Zhang Q, Pang W, Hou L, Liang Y, Han X, Luo X, Wang P, Zhang X, Li L and Meng X: YTHDC1-mediated augmentation of miR-30d in repressing pancreatic tumorigenesis via attenuation of RUNX1-induced transcriptional activation of Warburg effect. Cell Death Differ. 28:3105–3124. 2021. View Article : Google Scholar : PubMed/NCBI

Bian Y, Xu S, Gao Z, Ding J, Li C, Cui Z, Sun H, Li J, Pu J and Wang K: m⁶A modification of lncRNA ABHD11-AS1 promotes colorectal cancer progression and inhibits ferroptosis through TRIM21/IGF2BP2/FOXM1 positive feedback loop. Cancer Lett. 596:2170042024. View Article : Google Scholar

Zhao K, Chen L, Xie Y, Ren N, Li J, Zhai X, Zheng S, Liu K, Wang C, Qiu Q, et al: m6A/HOXA10-AS/ITGA6 axis aggravates oxidative resistance and malignant progression of laryngeal squamous cell carcinoma through regulating Notch and Keap1/Nrf2 pathways. Cancer Lett. 587:2167352024. View Article : Google Scholar : PubMed/NCBI

Shi Q, Li Z, Dong Y, Yang G and Li M: LncRNA THRIL, transcriptionally activated by AP-1 and stabilized by METTL14-mediated m6A modification, accelerates LPS-evoked acute injury in alveolar epithelial cells. Int Immunopharmacol. 123:1107402023. View Article : Google Scholar : PubMed/NCBI

Lin Z, Huang Z, Qiu J, Shi Y, Zuo D, Qiu Z, He W, Niu Y, Yuan Y and Li B: m⁶A-mediated lnc-OXAR promotes oxaliplatin resistance by enhancing Ku70 stability in non-alcoholic steatohepatitis-related hepatocellular carcinoma. J Exp Clin Cancer Res. 43:2062024. View Article : Google Scholar

Yang N, Yan N, Bai Z, Du S, Zhang J, Zhang L and Zhang Z: FTO attenuates LPS-induced acute kidney injury by inhibiting autophagy via regulating SNHG14/miR-373-3p/ATG7 axis. Int Immunopharmacol. 128:1114832024. View Article : Google Scholar : PubMed/NCBI

Zhang Y, Liu X, Wang Y, Lai S, Wang Z, Yang Y, Liu W, Wang H and Tang B: The m⁶A demethylase ALKBH5-mediated upregulation of DDIT4-AS1 maintains pancreatic cancer stemness and suppresses chemosensitivity by activating the mTOR pathway. Mol Cancer. 21:1742022. View Article : Google Scholar

Chen S, Duan X, He Y and Chen W: METTL3 promotes osteogenic differentiation of human umbilical cord mesenchymal stem cells by up-regulating m6A modification of circCTTN. Biosci Rep. 44:BSR202311862024. View Article : Google Scholar : PubMed/NCBI

Fan HN, Chen ZY, Chen XY, Chen M, Yi YC, Zhu JS and Zhang J: METTL14-mediated m⁶A modification of circORC5 suppresses gastric cancer progression by regulating miR-30c-2-3p/AKT1S1 axis. Mol Cancer. 21:512022. View Article : Google Scholar

Du X, Shi L, Wang B and Zhang G: WTAP mediated m6A-modified circ_0056856 contributes to the proliferation, migration, and invasion of IL-22-stimulated human keratinocyte by miR-197-3p/CDK1 axis. Arch Dermatol Res. 316:2082024. View Article : Google Scholar : PubMed/NCBI

Chen Y, Ling Z, Cai X, Xu Y, Lv Z, Man D, Ge J, Yu C, Zhang D, Zhang Y, et al: Activation of YAP1 by N6-methyladenosine-modified circCPSF6 drives malignancy in hepatocellular carcinoma. Cancer Res. 82:599–614. 2022. View Article : Google Scholar

Zhu X and Zhang P: m6A-modified circXPO1 accelerates colorectal cancer progression via interaction with FMRP to promote WWC2 mRNA decay. J Transl Med. 22:9312024. View Article : Google Scholar : PubMed/NCBI

Wu X, Fang Y, Gu Y, Shen H, Xu Y, Xu T, Shi R, Xu D, Zhang J, Leng K, et al: Fat mass and obesity-associated protein (FTO) mediated m⁶A modification of circFAM192A promoted gastric cancer proliferation by suppressing SLC7A5 decay. Mol Biomed. 5:112024. View Article : Google Scholar

Kong Z, Lu Y, Yang Y, Chang K, Lin Y, Huang Y, Wang C, Zhang L, Xu W, Zhao S and Li Y: m6A-mediated biogenesis of circDDIT4 inhibits prostate cancer progression by sequestrating ELAVL1/HuR. Mol Cancer Res. 21:1342–1355. 2023. View Article : Google Scholar :

Xu Y, Weng X, Qiu J and Wang S: Biogenesis of circRBM33 mediated by N6-methyladenosine and its function in abdominal aortic aneurysm. Epigenetics. 19:23924012024. View Article : Google Scholar : PubMed/NCBI

Wei Y, Fu J, Zhang H, Ling Y, Tang X, Liu S, Yu M, Liu F, Zhuang G, Qian H, et al: N6-methyladenosine modification promotes hepatocarcinogenesis through circ-CDYL-enriched and EpCAM-positive liver tumor-initiating exosomes. iScience. 26:1080222023. View Article : Google Scholar : PubMed/NCBI

Rao X, Lai L, Li X, Wang L, Li A and Yang Q: N⁶-methyladenosine modification of circular RNA circ-ARL3 facilitates Hepatitis B virus-associated hepatocellular carcinoma via sponging miR-1305. IUBMB Life. 73:408–417. 2021. View Article : Google Scholar

Liu Z, Wang T, She Y, Wu K, Gu S, Li L, Dong C, Chen C and Zhou Y: N⁶-methyladenosine-modified circIGF2BP3 inhibits CD8(+) T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer. Mol Cancer. 20:1052021. View Article : Google Scholar

Dattilo D, Di Timoteo G, Setti A, Giuliani A, Peruzzi G, Nebot MB, Centrón-Broco A, Mariani D, Mozzetta C and Bozzoni I: The m⁶A reader YTHDC1 and the RNA helicase DDX5 control the production of rhabdomyosarcoma-enriched circRNAs. Nat Commun. 14:18982023. View Article : Google Scholar

Wu X, Fu M, Ge C, Zhou H, Huang H, Zhong M, Zhang M, Xu H, Zhu G, Hua W, et al: m(6)A-mediated upregulation of lncRNA CHASERR promotes the progression of glioma by modulating the miR-6893-3p/TRIM14 axis. Mol Neurobiol. 61:5418–5440. 2024. View Article : Google Scholar : PubMed/NCBI

Wu W, Li X, Zhou Z, He H, Pang C, Ye S and Quan JH: METTL14 regulates inflammation in ulcerative colitis via the lncRNA DHRS4-AS1/miR-206/A3AR axis. Cell Biol Toxicol. 40:952024. View Article : Google Scholar : PubMed/NCBI

Liu P, Zhang B, Chen Z, He Y, Du Y, Liu Y and Chen X: m⁶A-induced lncRNA MALAT1 aggravates renal fibrogenesis in obstructive nephropathy through the miR-145/FAK pathway. Aging (Albany NY). 12:5280–5299. 2020. View Article : Google Scholar : PubMed/NCBI

Yu H and Zhang Z: ALKBH5-mediated m6A demethylation of lncRNA RMRP plays an oncogenic role in lung adenocarcinoma. Mamm Genome. 32:195–203. 2021. View Article : Google Scholar : PubMed/NCBI

Liu H, Liang J, Dai X, Peng Y, Xiong W, Zhang L, Li X, Li W, Liu K, Bi S, et al: Transcriptome-wide N6-methyladenosine (m6A) methylation profiling of long non-coding RNAs in ovarian endometriosis. Genomics. 116:1108032024. View Article : Google Scholar : PubMed/NCBI

Yin H, Chen L, Piao S, Wang Y, Li Z, Lin Y, Tang X, Zhang H, Zhang H and Wang X: M6A RNA methylation-mediated RMRP stability renders proliferation and progression of non-small cell lung cancer through regulating TGFBR1/SMAD2/SMAD3 pathway. Cell Death Differ. 30:605–617. 2023. View Article : Google Scholar :

Chang M, Cui X, Sun Q, Wang Y, Liu J, Sun Z, Ren J, Sun Y, Han L and Li W: Lnc-PLCB1 is stabilized by METTL14 induced m6A modification and inhibits Helicobacter pylori mediated gastric cancer by destabilizing DDX21. Cancer Lett. 588:2167462024. View Article : Google Scholar : PubMed/NCBI

Xie R, Liu L, Lu X, He C, Yao H and Li G: N6-methyladenosine modification of OIP5-AS1 promotes glycolysis, tumorigenesis, and metastasis of gastric cancer by inhibiting Trim21-mediated hnRNPA1 ubiquitination and degradation. Gastric Cancer. 27:49–71. 2024. View Article : Google Scholar :

Luo XJ, Lu YX, Wang Y, Huang R, Liu J, Jin Y, Liu ZK, Liu ZX, Huang QT, Pu H, et al: M6A-modified lncRNA FAM83H-AS1 promotes colorectal cancer progression through PTBP1. Cancer Lett. 598:2170852024. View Article : Google Scholar : PubMed/NCBI

Liu N, Jiang X, Zhang G, Long S, Li J, Jiang M, Jia G, Sun R, Zhang L and Zhang Y: LncRNA CARMN m6A demethylation by ALKBH5 inhibits mutant p53-driven tumour progression through miR-5683/FGF2. Clin Transl Med. 14:e17772024. View Article : Google Scholar : PubMed/NCBI

Yao L, Li T, Teng Y, Guo J, Zhang H, Xia L and Wu Q: ALKHB5-demethylated lncRNA SNHG15 promotes myeloma tumorigenicity by increasing chromatin accessibility and recruiting H3K36me3 modifier SETD2. Am J Physiol Cell Physiol. 326:C684–C697. 2024. View Article : Google Scholar :

Fang D, Ou X, Sun K, Zhou X, Li Y, Shi P, Zhao Z, He Y, Peng J and Xu J: m6A modification-mediated lncRNA TP53TG1 inhibits gastric cancer progression by regulating CIP2A stability. Cancer Sci. 113:4135–4150. 2022. View Article : Google Scholar : PubMed/NCBI

Wang J, Zhang J, Liu H, Meng L, Gao X, Zhao Y, Wang C, Gao X, Fan A, Cao T, et al: N6-methyladenosine reader hnRNPA2B1 recognizes and stabilizes NEAT1 to confer chemoresistance in gastric cancer. Cancer Commun (Lond). 44:469–490. 2024. View Article : Google Scholar : PubMed/NCBI

Yi J, Ma X, Ying Y, Liu Z, Tang Y, Shu X, Sun J, Wu Y, Lu D, Wang X, et al: N6-methyladenosine-modified CircPSMA7 enhances bladder cancer malignancy through the miR-128-3p/MAPK1 axis. Cancer Lett. 585:2166132024. View Article : Google Scholar : PubMed/NCBI

Xu C, Zhou J, Zhang X, Kang X, Liu S, Song M, Chang C, Lin Y and Wang Y: N(6)-methyladenosine-modified circ_104797 sustains cisplatin resistance in bladder cancer through acting as RNA sponges. Cell Mol Biol Lett. 29:282024. View Article : Google Scholar

Li H, Lin R, Zhang Y, Zhu Y, Huang S, Lan J, Lu N, Xie C, He S and Zhang W: N6-methyladenosine-modified circPLPP4 sustains cisplatin resistance in ovarian cancer cells via PIK3R1 upregulation. Mol Cancer. 23:52024. View Article : Google Scholar : PubMed/NCBI

Jiang S, Gao L, Li J, Zhang F, Zhang Y and Liu J: N6-methyladenosine-modified circ_0000337 sustains bortezomib resistance in multiple myeloma by regulating DNA repair. Front Cell Dev Biol. 12:13832322024. View Article : Google Scholar : PubMed/NCBI

Li J, Xu X, Xu K, Zhou X, Wu K, Yao Y, Liu Z, Chen C, Wang L, Sun Z, et al: N6-methyladenosine-modified circSLCO1B3 promotes intrahepatic cholangiocarcinoma progression via regulating HOXC8 and PD-L1. J Exp Clin Cancer Res. 43:1192024. View Article : Google Scholar : PubMed/NCBI

Zhu X, Li W, Lu M, Shang J, Zhou J, Lin L, Liu Y, Xing J, Zhang M, Zhao S, et al: M⁶A demethylase FTO-stabilized exosomal circBRCA1 alleviates oxidative stress-induced granulosa cell damage via the miR-642a-5p/FOXO1 axis. J Nanobiotechnology. 22:3672024. View Article : Google Scholar

Li L, Chen J, Wang A and Yi K: ALKBH5 regulates ovarian cancer growth via demethylating long noncoding RNA PVT1 in ovarian cancer. J Cell Mol Med. 28:e180662024. View Article : Google Scholar :

Shen W, Pu J, Zuo Z, Gu S, Sun J, Tan B, Wang L, Cheng J and Zuo Y: The RNA demethylase ALKBH5 promotes the progression and angiogenesis of lung cancer by regulating the stability of the LncRNA PVT1. Cancer Cell Int. 22:3532022. View Article : Google Scholar : PubMed/NCBI

Li K, Gong Q, Xiang XD, Guo G, Liu J, Zhao L, Li J, Chen N, Li H, Zhang LJ, et al: HNRNPA2B1-mediated m⁶A modification of lncRNA MEG3 facilitates tumorigenesis and metastasis of non-small cell lung cancer by regulating miR-21-5p/PTEN axis. J Transl Med. 21:3822023. View Article : Google Scholar

Dong F, Qin X, Wang B, Li Q, Hu J, Cheng X, Guo D, Cheng F, Fang C, Tan Y, et al: ALKBH5 facilitates hypoxia-induced paraspeckle assembly and IL8 secretion to generate an immunosuppressive tumor microenvironment. Cancer Res. 81:5876–5888. 2021. View Article : Google Scholar : PubMed/NCBI

Hu J, Duan H, Zou J, Ding W, Wei Z, Peng Q, Li Z, Duan R, Sun J and Zhu J: METTL3-dependent N6-methyladenosine modification is involved in berberine-mediated neuroprotection in ischemic stroke by enhancing the stability of NEAT1 in astrocytes. Aging (Albany NY). 16:299–321. 2024.PubMed/NCBI

Chang YZ, Chai RC, Pang B, Chang X, An SY, Zhang KN, Jiang T and Wang YZ: METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-κB to promote the malignant progression of IDH-wildtype glioma. Cancer Lett. 511:36–46. 2021. View Article : Google Scholar : PubMed/NCBI

Zhang Y, Xu Y, Qiu G, Luo Y, Bao Y, Lu J, Wang T and Wang Y: METTL3 mediated MALAT1 m6A modification promotes proliferation and metastasis in osteosarcoma cells. Mol Biotechnol. 66:3538–3548. 2024. View Article : Google Scholar

Han L, Lei G, Chen Z, Zhang Y, Huang C and Chen W: IGF2BP2 regulates MALAT1 by serving as an N6-methyladenosine reader to promote NSCLC proliferation. Front Mol Biosci. 8:7800892021. View Article : Google Scholar

Lu S, Han L, Hu X, Sun T, Xu D, Li Y, Chen Q, Yao W, He M, Wang Z, et al: N6-methyladenosine reader IMP2 stabilizes the ZFAS1/OLA1 axis and activates the Warburg effect: Implication in colorectal cancer. J Hematol Oncol. 14:1882021. View Article : Google Scholar : PubMed/NCBI

Peng J, Zheng H, Liu F, Wu Q and Liu S: The m6A methyltransferase METTL3 affects autophagy and progression of nasopharyngeal carcinoma by regulating the stability of lncRNA ZFAS1. Infect Agent Cancer. 17:12022. View Article : Google Scholar : PubMed/NCBI

Zhou X, Yang Y, Li Y, Liang G, Kang D, Zhou B and Li Q: METTL3 contributes to osteosarcoma progression by increasing DANCR mRNA stability via m6A modification. Front Cell Dev Biol. 9:7847192021. View Article : Google Scholar

Hu X, Peng WX, Zhou H, Jiang J, Zhou X, Huang D, Mo YY and Yang L: IGF2BP2 regulates DANCR by serving as an N6-methyladenosine reader. Cell Death Differ. 27:1782–1794. 2020. View Article : Google Scholar :

Wu S, Chi C, Weng S, Zhou W and Liu Z: IGF2BP2 promotes lncRNA DANCR stability mediated glycolysis and affects the progression of FLT3-ITD + acute myeloid leukemia. Apoptosis. 28:1035–1047. 2023. View Article : Google Scholar : PubMed/NCBI

Rong D, Dong Q, Qu H, Deng X, Gao F, Li Q and Sun P: m(6) A-induced LINC00958 promotes breast cancer tumorigenesis via the miR-378a-3p/YY1 axis. Cell Death Discov. 7:272021. View Article : Google Scholar

Zuo X, Chen Z, Gao W, Zhang Y, Wang J, Wang J, Cao M, Cai J, Wu J and Wang X: M6A-mediated upregulation of LINC00958 increases lipogenesis and acts as a nanotherapeutic target in hepatocellular carcinoma. J Hematol Oncol. 13:52020. View Article : Google Scholar : PubMed/NCBI

Yang D, Chang S, Li F, Ma M, Yang J, Lv X, Huangfu L and Jia C: m⁶ A transferase KIAA1429-stabilized LINC00958 accelerates gastric cancer aerobic glycolysis through targeting GLUT1. IUBMB Life. 73:1325–1333. 2021. View Article : Google Scholar : PubMed/NCBI

Zhuang S, Ma Y, Zeng Y, Lu C, Yang F, Jiang N, Ge J, Ju H, Zhong C, Wang J, et al: METTL14 promotes doxorubicin-induced cardiomyocyte ferroptosis by regulating the KCNQ1OT1-miR-7-5p-TFRC axis. Cell Biol Toxicol. 39:1015–1035. 2023. View Article : Google Scholar

Zhou Z, Cao Y, Yang Y, Wang S and Chen F: METTL3-mediated m⁶A modification of lnc KCNQ1OT1 promotes doxorubicin resistance in breast cancer by regulating miR-103a-3p/MDR1 axis. Epigenetics. 18:22170332023. View Article : Google Scholar

Li Y, Yan B, Wang X, Li Q, Kan X, Wang J, Sun Y, Wang P, Tian L and Liu M: ALKBH5-mediated m6A modification of lncRNA KCNQ1OT1 triggers the development of LSCC via upregulation of HOXA9. J Cell Mol Med. 26:385–398. 2022. View Article : Google Scholar

Ji F, Lu Y, Chen S, Lin X, Yu Y, Zhu Y and Luo X: m⁶A methyltransferase METTL3-mediated lncRNA FOXD2-AS1 promotes the tumorigenesis of cervical cancer. Mol Ther Oncolytics. 22:574–581. 2021. View Article : Google Scholar : PubMed/NCBI

Ren Z, Hu Y, Sun J, Kang Y, Li G and Zhao H: N⁶-methyladenosine methyltransferase WTAP-stabilized FOXD2-AS1 promotes the osteosarcoma progression through m(6)A/FOXM1 axis. Bioengineered. 13:7963–7973. 2022. View Article : Google Scholar : PubMed/NCBI

Lang C, Yin C, Lin K, Li Y, Yang Q, Wu Z, Du H, Ren D, Dai Y and Peng X: m⁶ A modification of lncRNA PCAT6 promotes bone metastasis in prostate cancer through IGF2BP2-mediated IGF1R mRNA stabilization. Clin Transl Med. 11:e4262021. View Article : Google Scholar

Liu HT, Zou YX, Zhu WJ, Sen-Liu, Zhang GH, Ma RR, Guo XY and Gao P: lncRNA THAP7-AS1, transcriptionally activated by SP1 and post-transcriptionally stabilized by METTL3-mediated m6A modification, exerts oncogenic properties by improving CUL4B entry into the nucleus. Cell Death Differ. 29:627–641. 2022. View Article : Google Scholar :

Zheng Y, Wang Y, Liu Y, Xie L, Ge J, Yu G and Zhao G: N6-methyladenosine modification of PTTG3P contributes to colorectal cancer proliferation via YAP1. Front Oncol. 11:6697312021. View Article : Google Scholar : PubMed/NCBI

Huang T, Cao L, Feng N, Xu B, Dong Y and Wang M: N⁶-methyladenosine (m(6)A)-mediated lncRNA DLGAP1-AS1enhances breast canceradriamycin resistance through miR-299-3p/WTAP feedback loop. Bioengineered. 12:10935–10944. 2021. View Article : Google Scholar : PubMed/NCBI

Liu H, Qin S, Liu C, Jiang L, Li C, Yang J, Zhang S, Yan Z, Liu X, Yang J and Sun X: m⁶A reader IGF2BP2-stabilized CASC9 accelerates glioblastoma aerobic glycolysis by enhancing HK2 mRNA stability. Cell Death Discov. 7:2922021. View Article : Google Scholar

Xue L, Li J, Lin Y, Liu D, Yang Q, Jian J and Peng J: m⁶ A transferase METTL3-induced lncRNA ABHD11-AS1 promotes the Warburg effect of non-small-cell lung cancer. J Cell Physiol. 236:2649–2658. 2021. View Article : Google Scholar

Wu P, Fang X, Liu Y, Tang Y, Wang W, Li X and Fan Y: N6-methyladenosine modification of circCUX1 confers radio-resistance of hypopharyngeal squamous cell carcinoma through caspase1 pathway. Cell Death Dis. 12:2982021. View Article : Google Scholar

Ji F, Lu Y, Chen S, Yu Y, Lin X, Zhu Y and Luo X: IGF2BP2-modified circular RNA circARHGAP12 promotes cervical cancer progression by interacting m(6)A/FOXM1 manner. Cell Death Discov. 7:2152021. View Article : Google Scholar : PubMed/NCBI

Cheng X, Yang H, Chen Y, Zeng Z, Liu Y, Zhou X, Zhang C, Xie A and Wang G: METTL3-mediated m⁶A modification of circGLIS3 promotes prostate cancer progression and represents a potential target for ARSI therapy. Cell Mol Biol Lett. 29:1092024. View Article : Google Scholar

Wu Q, Yin X, Zhao W, Xu W and Chen L: Molecular mechanism of m⁶A methylation of circDLC1 mediated by RNA methyltransferase METTL3 in the malignant proliferation of glioma cells. Cell Death Discov. 8:2292022. View Article : Google Scholar

Shu X, Yi J, Li J, Ying Y, Tang Y, Chen Z, Wang J, Zhang F, Lu D, Wu Y, et al: N6-methyladenosine-modified circRPS6KC1 regulated cellular senescence in prostate cancer via FOXM1/PCNA axis. Cell Signal. 125:1115102025. View Article : Google Scholar

Tian Q, Mu Q, Liu S, Huang K, Tang Y, Zhang P, Zhao J and Shu C: m6A-modified circASXL1 promotes proliferation and migration of ovarian cancer through the miR-320d/RACGAP1 axis. Carcinogenesis. 44:859–870. 2023. View Article : Google Scholar : PubMed/NCBI

Wu G, Hou Q, Liu Z, Pu Z and Wu L: N⁶-methyladenosine-modified circ_0006168 promotes epithelial mesenchymal transition via miR-384/STAT3/Snail axis in esophageal squamous cell carcinoma. J Cancer. 15:4939–4954. 2024. View Article : Google Scholar :

Zhang Y, Yang H, Long Y, Zhang Y, Chen R, Shi J and Chen J: circRNA N6-methyladenosine methylation in preeclampsia and the potential role of N6-methyladenosine-modified circPAPPA2 in trophoblast invasion. Sci Rep. 11:243572021. View Article : Google Scholar : PubMed/NCBI

Liang L, Zhu Y, Li J, Zeng J and Wu L: ALKBH5-mediated m6A modification of circCCDC134 facilitates cervical cancer metastasis by enhancing HIF1A transcription. J Exp Clin Cancer Res. 41:2612022. View Article : Google Scholar : PubMed/NCBI

Huang R, Sun M, Wang W, Yu X and Liu F: YTHDF2 alleviates microglia activation via promoting circHIPK2 degradation. J Neuroimmunol. 387:5782652024. View Article : Google Scholar

Shao Y, Liu Z, Song X, Sun R, Zhou Y, Zhang D, Sun H, Huang J, Wu C, Gu W, et al: ALKBH5/YTHDF2-mediated m6A modification of circAFF2 enhances radiosensitivity of colorectal cancer by inhibiting Cullin neddylation. Clin Transl Med. 13:e13182023. View Article : Google Scholar : PubMed/NCBI

Wang D, Guan H and Xia Y: YTHDC1 maintains trophoblasts function by promoting degradation of m6A-modified circMPP1. Biochem Pharmacol. 210:1154562023. View Article : Google Scholar : PubMed/NCBI

Yu J, Li W, Hou GJ, Sun DP, Yang Y, Yuan SX, Dai ZH, Yin HZ, Sun SH, Huang G, et al: Circular RNA cFAM210A, degradable by HBx, inhibits HCC tumorigenesis by suppressing YBX1 transactivation. Exp Mol Med. 55:2390–2401. 2023. View Article : Google Scholar : PubMed/NCBI

Chen X, Zhu S, Li HD, Wang JN, Sun LJ, Xu JJ, Hui YR, Li XF, Li LY, Zhao YX, et al: N(6)-methyladenosine-modified circIRF2, identified by YTHDF2, suppresses liver fibrosis via facilitating FOXO3 nuclear translocation. Int J Biol Macromol. 248:1258112023. View Article : Google Scholar : PubMed/NCBI

Chen RX, Chen X, Xia LP, Zhang JX, Pan ZZ, Ma XD, Han K, Chen JW, Judde JG, Deas O, et al: N⁶-methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis. Nat Commun. 10:46952019. View Article : Google Scholar

Ding P, Wu H, Wu J, Li T, He J, Ju Y, Liu Y, Li F, Deng H, Gu R, et al: N6-methyladenosine modified circPAK2 promotes lymph node metastasis via targeting IGF2BPs/VEGFA signaling in gastric cancer. Oncogene. 43:2548–2563. 2024. View Article : Google Scholar

Zhou M, Liu Y, Xu H, Chen X, Zheng N, Duan Z, Ge Y, Li D, Lin T, Zeng R, et al: YTHDC1-Modified m6A methylation of Hsa_circ_0102678 promotes keratinocyte inflammation induced by cutibacterium acnes biofilm through regulating miR-146a/TRAF6 and IRAK1 axis. J Innate Immun. 15:822–835. 2023. View Article : Google Scholar : PubMed/NCBI

Zeng W, Zhu JF, Guo J, Huang GJ, Ai LS, Zeng Y and Liao WJ: m⁶A-modified circFNDC3B inhibits colorectal cancer stemness and metastasis via RNF41-dependent ASB6 degradation. Cell Death Dis. 13:10082022. View Article : Google Scholar

Lin H, Cui Z, Tiange E, Xu H, Wang D, Wang P, Ruan X, Liu L and Xue Y: M6A-methylated circPOLR2B forms an R-loop and regulates the biological behavior of glioma stem cells through positive feedback loops. Cell Death Dis. 15:5542024. View Article : Google Scholar : PubMed/NCBI

Song M, Yao H, Sun Z, Chen D, Xu X, Long G, Wu L and Hu W: METTL3/YTHDC1-medicated m6A modification of circRNA3634 regulates the proliferation and differentiation of antler chondrocytes by miR-124486-5-MAPK1 axis. Cell Mol Biol Lett. 28:1012023. View Article : Google Scholar : PubMed/NCBI

Rong D, Wu F, Lu C, Sun G, Shi X, Chen X, Dai Y, Zhong W, Hao X, Zhou J, et al: m6A modification of circHPS5 and hepatocellular carcinoma progression through HMGA2 expression. Mol Ther Nucleic Acids. 26:637–648. 2021. View Article : Google Scholar : PubMed/NCBI

Zhang R, Yang R, Huang Z, Xu X, Lv S, Guan X, Li H and Wu J: METTL3/YTHDC1-mediated upregulation of LINC00294 promotes hepatocellular carcinoma progression. Heliyon. 9:e225952023. View Article : Google Scholar : PubMed/NCBI

Ouyang L, Sun MM, Zhou PS, Ren YW, Liu XY, Wei WY, Song ZS, Lu K and Yang LX: LncRNA FOXD1-AS1 regulates pancreatic cancer stem cell properties and 5-FU resistance by regulating the miR-570-3p/SPP1 axis as a ceRNA. Cancer Cell Int. 24:42024. View Article : Google Scholar : PubMed/NCBI

Shu G, Zhao Z, Zhao T, Deng C, Zhu J, Han Y, Chen M, Jing J, Bai G, Li D, et al: N(6)-methyladenosine modification of circMARK2 enhances cytoplasmic export and stabilizes LIN28B, contributing to the progression of Wilms tumor. J Exp Clin Cancer Res. 43:1912024. View Article : Google Scholar : PubMed/NCBI

Li H, Tang Y, Ruan X, Zhang J, Liu H, Yu S, Chen H, Yang H, Zhang K and Chen K: N6-methyladenosine-modified circTEAD1 stabilizes Yap1 mRNA to promote chordoma tumorigenesis. Clin Transl Med. 14:e16582024. View Article : Google Scholar : PubMed/NCBI

Zheng Z, Zeng X, Zhu Y, Leng M, Zhang Z, Wang Q, Liu X, Zeng S, Xiao Y, Hu C, et al: CircPPAP2B controls metastasis of clear cell renal cell carcinoma via HNRNPC-dependent alternative splicing and targeting the miR-182-5p/CYP1B1 axis. Mol Cancer. 23:42024. View Article : Google Scholar : PubMed/NCBI

Li J, Cao H, Yang J and Wang B: IGF2BP2-m6A-circMMP9 axis recruits ETS1 to promote TRIM59 transcription in laryngeal squamous cell carcinoma. Sci Rep. 14:30142024. View Article : Google Scholar : PubMed/NCBI

Mamontova V, Trifault B, Gribling-Burrer AS, Bohn P, Boten L, Preckwinkel P, Gallant P, Solvie D, Ade CP, Papadopoulos D, et al: NEAT1 promotes genome stability via m(6)A methylation-dependent regulation of CHD4. Genes Dev. 38:915–930. 2024. View Article : Google Scholar : PubMed/NCBI

Jiang T, Qi J, Xue Z, Liu B, Liu J, Hu Q, Li Y, Ren J, Song H, Xu Y, et al: The m⁶A modification mediated-lncRNA POU6F2-AS1 reprograms fatty acid metabolism and facilitates the growth of colorectal cancer via upregulation of FASN. Mol Cancer. 23:552024. View Article : Google Scholar

Olazagoitia-Garmendia A, Rojas-Márquez H, SebastiandelaCruz M, Agirre-Lizaso A, Ochoa A, Mendoza-Gomez LM, Perugorria MJ, Bujanda L, Madrigal AH, Santin I and Castellanos-Rubio A: m⁶A methylated long noncoding RNA LOC339803 regulates intestinal inflammatory response. Adv Sci (Weinh). 11:e23079282024. View Article : Google Scholar

Vaid R, Thombare K, Mendez A, Burgos-Panadero R, Djos A, Jachimowicz D, Lundberg KI, Bartenhagen C, Kumar N, Tümmler C, et al: METTL3 drives telomere targeting of TERRA lncRNA through m6A-dependent R-loop formation: A therapeutic target for ALT-positive neuroblastoma. Nucleic Acids Res. 52:2648–2671. 2024. View Article : Google Scholar : PubMed/NCBI

Liu R, Zhong Y, Chen R, Chu C, Liu G, Zhou Y, Huang Y, Fang Z and Liu H: m⁶A reader hnRNPA2B1 drives multiple myeloma osteolytic bone disease. Theranostics. 12:7760–7774. 2022. View Article : Google Scholar :

Hu Z, Chen G, Zhao Y, Gao H, Li L, Yin Y, Jiang J, Wang L, Mang Y, Gao Y, et al: Exosome-derived circCCAR1 promotes CD8 + T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma. Mol Cancer. 22:552023. View Article : Google Scholar

Yu J, Gao Y, Liu F, Zhang Y, Li J, Ding L, Ren S, Yang J, Jiao J, Feng G, et al: m6A-modified exosome-derived circHIF1α binding to KH domain of IGF2BP3 mediates DNA damage and arrests G1/S transition phase to resists bacterial infection in bacteremia. J Nanobiotechnology. 22:6542024. View Article : Google Scholar

Wang Z, He J, Bach DH, Huang YH, Li Z, Liu H, Lin P and Yang J: Induction of m⁶A methylation in adipocyte exosomal LncRNAs mediates myeloma drug resistance. J Exp Clin Cancer Res. 41:42022. View Article : Google Scholar

Chen J, Zhou Y, Wu M, Yuan Y and Wu W: m6A modification mediates exosomal LINC00657 to trigger breast cancer progression via inducing macrophage M2 polarization. Clin Breast Cancer. 23:546–560. 2023. View Article : Google Scholar

He Z, Zhong Y, Regmi P, Lv T, Ma W, Wang J, Liu F, Yang S, Zhong Y, Zhou R, et al: Exosomal long non-coding RNA TRPM2-AS promotes angiogenesis in gallbladder cancer through interacting with PABPC1 to activate NOTCH1 signaling pathway. Mol Cancer. 23:652024. View Article : Google Scholar : PubMed/NCBI

Tuersun H, Liu L, Zhang J, Maimaitizunong R, Tang X and Li H: m6A reading protein RBMX as a biomarker for prognosis and tumor progression in esophageal cancer. Transl Cancer Res. 12:2319–2335. 2023. View Article : Google Scholar : PubMed/NCBI

Yang Y, Ren S, Xue J, Dong W, He W, Luo J, Li X, Xu H, Zheng Z, Wang X, et al: DeSUMOylation of RBMX regulates exosomal sorting of cargo to promote renal tubulointerstitial fibrosis in diabetic kidney disease. J Adv Res. 74:175–189. 2024. View Article : Google Scholar : PubMed/NCBI

Wu Z, Zuo X, Zhang W, Li Y, Gui R, Leng J, Shen H, Pan B, Fan L, Li J and Jin H: m6A-Modified circTET2 interacting with HNRNPC regulates fatty acid oxidation to promote the proliferation of chronic lymphocytic leukemia. Adv Sci (Weinh). 10:e23048952023. View Article : Google Scholar : PubMed/NCBI

Liu J, Shao Y and Li C: YTHDC1/CRM1 facilitates m6A-modified circRNA388 nuclear export to induce coelomocyte autophagy via the miR-2008/ULK axis in apostichopus japonicus. J Immunol. 212:1319–1333. 2024. View Article : Google Scholar : PubMed/NCBI

Wang L, Wang H, Liu T, Zhou X, Kuai S, Ji Z and Shen H: METTL3-mediated m(6)A modification of circCSDE1 promote Coxsackievirus replication by regulating the miR-891b/BAG3 axis. Int Immunopharmacol. 159:1149052025. View Article : Google Scholar : PubMed/NCBI

Wu A, Hu Y, Xu Y, Xu J, Wang X, Cai A, Liu R, Chen L and Wang F: Methyltransferase-like 3-mediated m6A methylation of Hsa_circ_0058493 accelerates hepatocellular carcinoma progression by binding to YTH domain-containing protein 1. Front Cell Dev Biol. 9:7625882021. View Article : Google Scholar : PubMed/NCBI

Yang L, Chen Y, Liu N, Lu Y, Ma W, Yang Z, Gan W and Li D: CircMET promotes tumor proliferation by enhancing CDKN2A mRNA decay and upregulating SMAD3. Mol Cancer. 21:232022. View Article : Google Scholar : PubMed/NCBI

Yang Y, Jiang C, Zeng J, Guo X, Chen M and Wu B: hsa_ circ_0001599 promotes odontogenic differentiation of human dental pulp stem cells by increasing ITGA2 expression and stability. Commun Biol. 8:742025. View Article : Google Scholar

He T, Zhang Q, Xu P, Tao W, Lin F, Liu R, Li M, Duan X, Cai C, Gu D, et al: Extracellular vesicle-circEHD2 promotes the progression of renal cell carcinoma by activating cancer-associated fibroblasts. Mol Cancer. 22:1172023. View Article : Google Scholar : PubMed/NCBI

Diao X, Guo C, Zheng H, Zhao K, Luo Y, An M, Lin Y, Chen J, Li Y, Li Y, et al: SUMOylation-triggered ALIX activation modulates extracellular vesicles circTLCD4-RWDD3 to promote lymphatic metastasis of non-small cell lung cancer. Signal Transduct Target Ther. 8:4262023. View Article : Google Scholar : PubMed/NCBI

Yao Y, Chen C, Wang J, Xuan H, Chen X, Li Z, Yang F, Wang B, Lin S, Li S, et al: Circular RNA circATP9A promotes non-small cell lung cancer progression by interacting with HuR and by promoting extracellular vesicles-mediated macrophage M2 polarization. J Exp Clin Cancer Res. 42:3302023. View Article : Google Scholar : PubMed/NCBI

Pan Z, Zhao R, Li B, Qi Y, Qiu W, Guo Q, Zhang S, Zhao S, Xu H, Li M, et al: EWSR1-induced circNEIL3 promotes glioma progression and exosome-mediated macrophage immunosuppressive polarization via stabilizing IGF2BP3. Mol Cancer. 21:162022. View Article : Google Scholar : PubMed/NCBI

Chen S, Wang Y, Zhang J, Liu B, Liu W, Cao G, Li R, Li H, Zhai N, Song X, et al: YTHDC1 phase separation drives the nuclear export of m(6)A-modified lncNONMMUT062668.2 through the transport complex SRSF3-ALYREF-XPO5 to aggravate pulmonary fibrosis. Cell Death Dis. 16:2792025. View Article : Google Scholar : PubMed/NCBI

Li T, Tian L, Cao J and Liu M: Cancer-associated fibroblasts secret extracellular vesicles to support cell proliferation and epithelial-mesenchymal transition in laryngeal squamous cell carcinoma. Mol Cell Probes. 72:1019342023. View Article : Google Scholar : PubMed/NCBI

Wang Y, Tian X, Wang Z, Liu D, Zhao X, Sun X, Tu Z, Li Z, Zhao Y, Zheng S and Yao J: A novel peptide encoded by circ-SLC9A6 promotes lipid dyshomeostasis through the regulation of H4K16ac-mediated CD36 transcription in NAFLD. Clin Transl Med. 14:e18012024. View Article : Google Scholar : PubMed/NCBI

Zeng K, Peng J, Xing Y, Zhang L, Zeng P, Li W, Zhang W, Pan Z, Zhou C and Lin J: A positive feedback circuit driven by m⁶A-modified circular RNA facilitates colorectal cancer liver metastasis. Mol Cancer. 22:2022023. View Article : Google Scholar

Zheng W, Wang L, Geng S and Xu T: CircYthdc2 generates polypeptides through two translation strategies to facilitate virus escape. Cell Mol Life Sci. 81:912024. View Article : Google Scholar : PubMed/NCBI

Li K, Peng ZY, Wang R, Li X, Du N, Liu DP, Zhang J, Zhang YF, Ma L, Sun Y, et al: Enhancement of TKI sensitivity in lung adenocarcinoma through m6A-dependent translational repression of Wnt signaling by circ-FBXW7. Mol Cancer. 22:1032023. View Article : Google Scholar : PubMed/NCBI

Zheng W, Wang L, Geng S, Yang L, Lv X, Xin S and Xu T: CircMIB2 therapy can effectively treat pathogenic infection by encoding a novel protein. Cell Death Dis. 14:5782023. View Article : Google Scholar : PubMed/NCBI

Tang C, Xie Y, Yu T, Liu N, Wang Z, Woolsey RJ, Tang Y, Zhang X, Qin W, Zhang Y, et al: m⁶A-dependent biogenesis of circular RNAs in male germ cells. Cell Res. 30:211–228. 2020. View Article : Google Scholar : PubMed/NCBI

Pan Z, Cai J, Lin J, Zhou H, Peng J, Liang J, Xia L, Yin Q, Zou B, Zheng J, et al: A novel protein encoded by circFNDC3B inhibits tumor progression and EMT through regulating Snail in colon cancer. Mol Cancer. 19:712020. View Article : Google Scholar : PubMed/NCBI

Xiong L, Gong Y, Liu H, Huang L, Zeng Z, Zheng X, Li W, Liang Z and Kang L: circGlis3 promotes β-cell dysfunction by binding to heterogeneous nuclear ribonucleoprotein F and encoding Glis3-348aa protein. iScience. 27:1086802024. View Article : Google Scholar

Sun W, Zhou S, Peng L, Liu Y, Cheng D, Wang Y and Ni C: CircZNF609 regulates pulmonary fibrosis via miR-145-5p/KLF4 axis and its translation function. Cell Mol Biol Lett. 28:1052023. View Article : Google Scholar :

Wu S, Zhang L, Deng J, Guo B, Li F, Wang Y, Wu R, Zhang S, Lu J and Zhou Y: A novel micropeptide encoded by Y-linked LINC00278 links cigarette smoking and AR signaling in male esophageal squamous cell carcinoma. Cancer Res. 80:2790–2803. 2020. View Article : Google Scholar : PubMed/NCBI

Pei H, Dai Y, Yu Y, Tang J, Cao Z, Zhang Y, Li B, Nie J, Hei TK and Zhou G: The tumorigenic effect of lncRNA AFAP1-AS1 is mediated by translated peptide ATMLP under the control of m⁶A methylation. Adv Sci (Weinh). 10:e23003142023. View Article : Google Scholar

Shen G, Li F, Wang Y, Huang Y, Aizezi G, Yuan J, Ma C and Lin C: New insights on the interaction between m⁶A modification and non-coding RNA in cervical squamous cell carcinoma. World J Surg Oncol. 21:252023. View Article : Google Scholar

Wu C, Cui J, Huo Y, Shi L and Wang C: Alternative splicing of HOXB-AS3 underlie the promoting effect of nuclear m6A reader YTHDC1 on the self-renewal of leukemic stem cells in acute myeloid leukemia. Int J Biol Macromol. 237:1239902023. View Article : Google Scholar

Leng F, Miu YY, Zhang Y, Luo H, Lu XL, Cheng H and Zheng ZG: A micro-peptide encoded by HOXB-AS3 promotes the proliferation and viability of oral squamous cell carcinoma cell lines by directly binding with IGF2BP2 to stabilize c-Myc. Oncol Lett. 22:6972021. View Article : Google Scholar : PubMed/NCBI

Lin M, Zhou X, Yang Y, Xie P, Li Q, He C, Lin Q, Wei X and Ding Y: A peptide encoded by lncRNA HOXB-AS3 promotes cigarette smoke-induced inflammation in bronchial epithelial cells via EZH2-Mediated H3K27me3 modification. Int J Chron Obstruct Pulmon Dis. 20:1543–1553. 2025. View Article : Google Scholar : PubMed/NCBI

Ge Q, Jia D, Cen D, Qi Y, Shi C, Li J, Sang L, Yang LJ, He J, Lin A, et al: Micropeptide ASAP encoded by LINC00467 promotes colorectal cancer progression by directly modulating ATP synthase activity. J Clin Invest. 131:e1529112021. View Article : Google Scholar : PubMed/NCBI

Zhang M, Cai R, Liu J, Wang Y, He S, Wang Q, Song X, Wu J and Zhao J: Multi-omics integration analysis reveals the role of N6-methyladenosine in lncRNA translation during glioma stem cell differentiation. Brief Funct Genomics. 23:806–815. 2024. View Article : Google Scholar : PubMed/NCBI

Zhong J, Wu X, Gao Y, Chen J, Zhang M, Zhou H, Yang J, Xiao F, Yang X, Huang N, et al: Circular RNA encoded MET variant promotes glioblastoma tumorigenesis. Nat Commun. 14:44672023. View Article : Google Scholar : PubMed/NCBI

Wang T, Liu Z, She Y, Deng J, Zhong Y, Zhao M, Li S, Xie D, Sun X, Hu X and Chen C: A novel protein encoded by circASK1 ameliorates gefitinib resistance in lung adenocarcinoma by competitively activating ASK1-dependent apoptosis. Cancer Lett. 520:321–331. 2021. View Article : Google Scholar : PubMed/NCBI

Lu J, Ru J, Chen Y, Ling Z, Liu H, Ding B, Jiang Y, Ma J, Zhang D, Ge J, et al: N⁶ -methyladenosine-modified circSTX6 promotes hepatocellular carcinoma progression by regulating the HNRNPD/ATF3 axis and encoding a 144 amino acid polypeptide. Clin Transl Med. 13:e14512023. View Article : Google Scholar

Li Y, Chen B, Zhao J, Li Q, Chen S, Guo T, Li Y, Lai H, Chen Z, Meng Z, et al: HNRNPL circularizes ARHGAP35 to produce an oncogenic protein. Adv Sci (Weinh). 8:20017012021. View Article : Google Scholar : PubMed/NCBI

Lan T, Gao F, Cai Y, Lv Y, Zhu J, Liu H, Xie S, Wan H, He H, Xie K, et al: The protein circPETH-147aa regulates metabolic reprogramming in hepatocellular carcinoma cells to remodel immunosuppressive microenvironment. Nat Commun. 16:3332025. View Article : Google Scholar : PubMed/NCBI

Zhong S, Xu H, Wang D, Yang S, Li H, Zhang H, Feng J and Zhou S: circNFIB decreases synthesis of arachidonic acid and inhibits breast tumor growth and metastasis. Eur J Pharmacol. 963:1762212024. View Article : Google Scholar

Wei C, Peng D, Jing B, Wang B, Li Z, Yu R, Zhang S, Cai J, Zhang Z, Zhang J and Han L: A novel protein SPECC1-415aa encoded by N6-methyladenosine modified circSPECC1 regulates the sensitivity of glioblastoma to TMZ. Cell Mol Biol Lett. 29:1272024. View Article : Google Scholar : PubMed/NCBI

Zhang Y, Liu Z, Zhong Z, Ji Y, Guo H, Wang W and Chen C: A tumor suppressor protein encoded by circKEAP1 inhibits osteosarcoma cell stemness and metastasis by promoting vimentin proteasome degradation and activating anti-tumor immunity. J Exp Clin Cancer Res. 43:522024. View Article : Google Scholar : PubMed/NCBI

Li M, Ding W, Fang X, Wang Y, Wang P, Ye L, Miao S, Song L, Ao X, Li Q and Wang J: Novel truncated peptide derived from circCDYL exacerbates cardiac hypertrophy. Circ Res. 136:e94–e112. 2025. View Article : Google Scholar : PubMed/NCBI

Zhou B, Yu G, Zhao M, Li Y, Li J, Xiang Y, Tong L, Chu X, Wang C and Song Y: The lncRNA LINC00339-encoded peptide promotes trophoblast adhesion to endometrial cells via MAPK and PI3K-Akt signaling pathways. J Assist Reprod Genet. 41:493–504. 2024. View Article : Google Scholar :

Zhu HX, Lu WJ, Zhu WP and Yu S: Comprehensive analysis of N⁶ -methyladenosine-related long non-coding RNAs for prognosis prediction in liver hepatocellular carcinoma. J Clin Lab Anal. 35:e240712021. View Article : Google Scholar

Xiao W, Halabi R, Lin CH, Nazim M, Yeom KH and Black DL: The lncRNA Malat1 is trafficked to the cytoplasm as a localized mRNA encoding a small peptide in neurons. Genes Dev. 38:294–307. 2024. View Article : Google Scholar :

Ming Y, Deng Z, Tian X, Jia Y, Ning M and Cheng S: m6A methyltransferase METTL3 reduces hippocampal neuron apoptosis in a mouse model of autism through the MALAT1/SFRP2/Wnt/β-catenin axis. Psychiatry Investig. 19:771–787. 2022. View Article : Google Scholar : PubMed/NCBI

Zheng W, Guo Y, Zhang G, Bai J, Song Y, Song X, Zhu Q, Bao X, Wu G and Zhang C: Peptide encoded by lncRNA BVES-AS1 promotes cell viability, migration, and invasion in colorectal cancer cells via the SRC/mTOR signaling pathway. PLoS One. 18:e02871332023. View Article : Google Scholar : PubMed/NCBI

Wu J, Cai Y, Zhao G and Li M: A ten N6-methyladenosine-related long non-coding RNAs signature predicts prognosis of triple-negative breast cancer. J Clin Lab Anal. 35:e237792021. View Article : Google Scholar : PubMed/NCBI

Min XL, Lin SX, Zhao XH, Zhao Q, Li YF, Li XH, Liu XY, Cao Y, Sun YL and Zeng Y: Mechanisms of METTL14-mediated m6A modification in promoting iron overload-induced lipid peroxidative damage in vascular endothelial cells to aggravate atherosclerosis. J Biochem Mol Toxicol. 38:e700662024. View Article : Google Scholar : PubMed/NCBI

Shen C, Chen X, Lin Y and Yang Y: Hypoxia triggers cardiomyocyte apoptosis via regulating the m⁶A methylation-mediated LncMIAT/miR-708-5p/p53 axis. Heliyon. 10:e324552024. View Article : Google Scholar

Fang X, Ao X, Xiao D, Wang Y, Jia Y, Wang P, Li M and Wang J: Circular RNA-circPan3 attenuates cardiac hypertrophy via miR-320-3p/HSP20 axis. Cell Mol Biol Lett. 29:32024. View Article : Google Scholar : PubMed/NCBI

Zhang HR, Ma GQ, Lv HQ, Feng YT and Peng YJ: Electroacupuncture alleviates cerebral ischemia-reperfusion injury by regulating the S1PR2/TLR4/NLRP3 signaling pathway via m6A methylation of lncRNA H19. Curr Neurovasc Res. 21:64–73. 2024. View Article : Google Scholar : PubMed/NCBI

Yu P, Wang J, Xu GE, Zhao X, Cui X, Feng J, Sun J, Wang T, Spanos M, Lehmann HI, et al: RNA m(6)A-Regulated circ-ZNF609 suppression ameliorates doxorubicin-induced cardiotoxicity by upregulating FTO. JACC Basic Transl Sci. 8:677–698. 2023. View Article : Google Scholar : PubMed/NCBI

Yuan J, Liu Y, Zhou L, Xue Y, Lu Z and Gan J: YTHDC2-mediated circYTHDC2 N6-methyladenosine modification promotes vascular smooth muscle Cells dysfunction through inhibiting ten-eleven translocation 2. Front Cardiovasc Med. 8:6862932021. View Article : Google Scholar : PubMed/NCBI

Tian Y, Xiao YH, Sun C, Liu B and Sun F: N6-Methyladenosine methyltransferase METTL3 alleviates diabetes-induced testicular damage through modulating TUG1/Clusterin axis. Diabetes Metab J. 47:287–300. 2023. View Article : Google Scholar : PubMed/NCBI

Fu S, Zhou Q, Peng X, Hu Y, Xiong J and Liu F: METTL3/YTHDC1 mediates up-regulation of lncRNA OGRU in an m6A-dependent manner involving in oxidative stress and inflammation of HG-induced Müller cells. Immunol Lett. 272:1069722025. View Article : Google Scholar

Li C, Su F, Liang Z, Zhang L, Liu F, Fan W and Li Z: Macrophage M1 regulatory diabetic nephropathy is mediated by m6A methylation modification of lncRNA expression. Mol Immunol. 144:16–25. 2022. View Article : Google Scholar : PubMed/NCBI

Guo C, Yu M, Liu J, Jia Z, Liu H and Zhao S: Molecular mechanism of Wilms tumour 1-associated protein in diabetes-related dry eye disease by mediating m6A methylation modification of lncRNA NEAT1. J Drug Target. 32:200–212. 2024. View Article : Google Scholar

Zheng M, Cun D, He H, Xie X, Lei H, Fu W, Tai W and Yang J: Expression profile and N6-methyadenosine modification of circular RNA analysis in MAFLD. BMC Gastroenterol. 25:1622025. View Article : Google Scholar : PubMed/NCBI

Zhang C, Jian H, Shang S, Lu L, Lou Y, Kang Y, Bai H, Fu Z, Lv Y, Kong X, et al: Crosstalk between m6A mRNAs and m6A circRNAs and the time-specific biogenesis of m6A circRNAs after OGD/R in primary neurons. Epigenetics. 18:21815752023. View Article : Google Scholar : PubMed/NCBI

Zhang X, Yang S, Han S, Sun Y, Han M, Zheng X, Li F, Wei Y, Wang Y and Bi J: Differential methylation of circRNA m6A in an APP/PS1 Alzheimer's disease mouse model. Mol Med Rep. 27:552023. View Article : Google Scholar : PubMed/NCBI

Liu X, Li Z, Tong J, Wu F, Jin H and Liu K: Characterization of the expressions and m6A methylation modification patterns of mRNAs and lncRNAs in a spinal cord injury rat model. Mol Neurobiol. 62:806–818. 2025. View Article : Google Scholar :

Atrian F, Ramirez P, De Mange J, Ramirez P, Atrian F, Morita M and Frost B: m6A-dependent circular RNA formation mediates tau-induced neurotoxicity. bioRxiv. 23:e142452024.

Zhang H, Xu X, Li X, Zeng C and Peng Y: Electroacupuncture serum alleviates Ogd/R-induced astrocyte damage by regulating the AQP4 Via m6A methylation of lncRNA MALAT1. Neurochem Res. 50:1392025. View Article : Google Scholar : PubMed/NCBI

Sun H, Liu F, Song X, Sun R, Zhang M, Huang J, Gu W and Shao Y: m6A-modified circCREBBP enhances radiosensitivity of esophageal squamous cell carcinoma by reducing the stability of MYC through interaction with IGF2BP3. Int J Biol Macromol. 286:1385342025. View Article : Google Scholar

Wang F, Wen J, Liu J, Xin L, Fang Y, Sun Y and He M: Demethylase FTO mediates m6A modification of ENST00000619282 to promote apoptosis escape in rheumatoid arthritis and the intervention effect of Xinfeng Capsule. Front Immunol. 16:15567642025. View Article : Google Scholar : PubMed/NCBI

Canaani J, Danylesko I, Shemtov N, Zlotnick M, Lozinsky K, Benjamini O, Yerushalmi R, Nagar M, Dor C, Shimoni A, et al: A phase II study of bisantrene in patients with relapsed/refractory acute myeloid leukemia. Eur J Haematol. 106:260–266. 2021. View Article : Google Scholar

Pomaville M, Chennakesavalu M, Wang P, Jiang Z, Sun HL, Ren P, Borchert R, Gupta V, Ye C, Ge R, et al: Small-molecule inhibition of the METTL3/METTL14 complex suppresses neuroblastoma tumor growth and promotes differentiation. Cell Rep. 43:1141652024. View Article : Google Scholar : PubMed/NCBI

Yankova E, Blackaby W, Albertella M, Rak J, De Braekeleer E, Tsagkogeorga G, Pilka ES, Aspris D, Leggate D, Hendrick AG, et al: Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia. Nature. 593:597–601. 2021. View Article : Google Scholar : PubMed/NCBI

Lee JH, Choi N, Kim S, Jin MS, Shen H and Kim YC: Eltrombopag as an allosteric inhibitor of the METTL3-14 complex affecting the m⁶A methylation of RNA in acute myeloid leukemia cells. Pharmaceuticals (Basel). 15:4402022. View Article : Google Scholar

Wu Z, Smith AR, Qian Z and Zheng G: Patent landscape of small molecule inhibitors of METTL3 (2020-present). Expert Opin Ther Pat. 26:1–16. 2024.

Wu J, Pang R, Li M, Chen B, Huang J and Zhu Y: m6A-Induced LncRNA MEG3 suppresses the proliferation, migration and invasion of hepatocellular carcinoma cell through miR-544b/BTG2 signaling. Onco Targets Ther. 14:3745–3755. 2021. View Article : Google Scholar : PubMed/NCBI

Li P, Mi Q, Yan S, Xie Y, Cui Z, Zhang S, Wang Y, Gao H, Wang Y, Li J, et al: Characterization of circSCL38A1 as a novel oncogene in bladder cancer via targeting ILF3/TGF-β2 signaling axis. Cell Death Dis. 14:592023. View Article : Google Scholar

Liu Q, Zhou BM, Wang LJ and Zhang CY: Construction of a hierarchical DNA circuit for single-molecule profiling of locus-specific N⁶-methyladenosine-MALAT1 in clinical tissues. Biosens Bioelectron. 274:1171982025. View Article : Google Scholar

Zhang J, Liu T, Wang Y, Yan X, Li Y, Xu F and Zhang R: Dynamic alterations of the transcriptome-wide m⁶A methylome in cytogenetically normal acute myeloid leukaemia during initial diagnosis and relapse. Genomics. 115:1107252023. View Article : Google Scholar